We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBH icon
1351
Sally Beauty Holdings
SBH
$1.58B
$5.05M 0.01%
273,823
-8,721
-3% -$159K
PRGS icon
1352
Progress Software
PRGS
$1.76B
$5.04M 0.01%
104,301
-4,420
-4% -$220K
WTM icon
1353
White Mountains Insurance
WTM
$5.13B
$5.03M 0.01%
4,961
+40
+0.8% +$42.3K
PSMT icon
1354
Pricesmart
PSMT
$5.46B
$5.02M 0.01%
68,554
+1,775
+3% +$133K
PACB icon
1355
Pacific Biosciences
PACB
$370M
$5.01M 0.01%
245,074
-3,129
-1% -$75.5K
PTEN icon
1356
Patterson-UTI
PTEN
$3.76B
$5.01M 0.01%
592,370
+43,606
+8% +$376K
GPRE icon
1357
Green Plains
GPRE
$1.03B
$5M 0.01%
143,749
+1,173
+0.8% +$43.6K
CHNG
1358
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$4.99M 0.01%
233,494
+6,676
+3% +$140K
HNI icon
1359
HNI Corp
HNI
$3.59B
$4.95M 0.01%
117,711
-716
-0.6% -$28.7K
AVNS
1360
DELISTED
Avanos Medical
AVNS
$4.95M 0.01%
142,711
+6,113
+4% +$198K
VRTV
1361
DELISTED
VERITIV CORPORATION
VRTV
$4.94M 0.01%
40,335
-479
-1% -$57.7K
GKOS icon
1362
Glaukos
GKOS
$10.6B
$4.94M 0.01%
111,068
+559
+0.5% +$25.8K
ILPT
1363
Industrial Logistics Properties Trust
ILPT
$586M
$4.93M 0.01%
196,668
-527
-0.3% -$13.3K
CRC icon
1364
California Resources
CRC
$4.62B
$4.93M 0.01%
115,342
-1,906
-2% -$81.5K
FBNC icon
1365
First Bancorp
FBNC
$2.68B
$4.91M 0.01%
107,365
+11,927
+12% +$559K
GEF icon
1366
Greif
GEF
$5.04B
$4.9M 0.01%
81,177
-662
-0.8% -$42.9K
ESI icon
1367
Element Solutions
ESI
$9.23B
$4.88M 0.01%
201,152
+4,506
+2% +$106K
MNRO icon
1368
Monro
MNRO
$398M
$4.88M 0.01%
83,810
-2,288
-3% -$135K
LZB icon
1369
La-Z-Boy
LZB
$1.69B
$4.87M 0.01%
134,073
+272
+0.2% +$9.49K
QS icon
1370
QuantumScape Corp
QS
$3.74B
$4.86M 0.01%
219,157
+37,894
+21% +$1.04M
TSE
1371
DELISTED
Trinseo
TSE
$4.83M 0.01%
92,147
-1,269
-1% -$68.7K
OI icon
1372
O-I Glass
OI
$1.08B
$4.83M 0.01%
401,784
-3,272
-0.8% -$41.5K
SNBR
1373
DELISTED
Sleep Number
SNBR
$4.83M 0.01%
63,079
-2,450
-4% -$205K
SCCO icon
1374
Southern Copper
SCCO
$166B
$4.83M 0.01%
84,345
+3,536
+4% +$197K
CALX icon
1375
Calix
CALX
$2.39B
$4.81M 0.01%
60,155
-595
-1% -$38.8K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.